NCT00650871 - A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 30, 2004

Primary Completion Date

August 30, 2005

Study Completion Date

August 30, 2005

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

DRUG

GW679769

DRUG

Placebo

Trial Locations (7)

GSK Investigational Site, New York

GSK Investigational Site, Philadelphia

GSK Investigational Site, Winston-Salem

GSK Investigational Site, Durham

GSK Investigational Site, Atlanta

GSK Investigational Site, Cincinnati

GSK Investigational Site, San Diego